These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21680807)

  • 1. Physician knowledge and awareness of CA-125 as a screen for ovarian cancer in the asymptomatic, average-risk population.
    Stewart SL; Rim SH; Gelb CA
    Health Educ Behav; 2012 Feb; 39(1):57-66. PubMed ID: 21680807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vignette-based study of ovarian cancer screening: do U.S. physicians report adhering to evidence-based recommendations?
    Baldwin LM; Trivers KF; Matthews B; Andrilla CH; Miller JW; Berry DL; Lishner DM; Goff BA
    Ann Intern Med; 2012 Feb; 156(3):182-94. PubMed ID: 22312138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compliance of average- and intermediate-risk women to semiannual ovarian cancer screening.
    Drescher CW; Nelson J; Peacock S; Andersen MR; McIntosh MW; Urban N
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):600-6. PubMed ID: 15066925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian cancer screening.
    van Nagell JR; Gallion HH; Pavlik EJ; DePriest PD
    Cancer; 1995 Nov; 76(10 Suppl):2086-91. PubMed ID: 8635005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Program for early detection of ovarian cancer for women as prophylaxis provided at a municipal hospital].
    Cnota W; Sodowski K; Olesiak-Andryszczak M; Pilch-Kowalczyk M
    Wiad Lek; 2004; 57 Suppl 1():43-7. PubMed ID: 15884203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the risk of ovarian malignancy in asymptomatic women with abnormal CA 125 and transvaginal ultrasound scans in the prostate, lung, colorectal, and ovarian screening trial.
    Partridge EE; Greenlee RT; Riley TL; Commins J; Ragard L; Xu JL; Buys SS; Prorok PC; Fouad MN
    Obstet Gynecol; 2013 Jan; 121(1):25-31. PubMed ID: 23262924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physician characteristics and beliefs associated with use of pelvic examinations in asymptomatic women.
    Stormo AR; Cooper CP; Hawkins NA; Saraiya M
    Prev Med; 2012 Jun; 54(6):415-21. PubMed ID: 22484240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian cancer screening in women with a family history of breast or ovarian cancer.
    Lacey JV; Greene MH; Buys SS; Reding D; Riley TL; Berg CD; Fagerstrom RM; Hartge P
    Obstet Gynecol; 2006 Nov; 108(5):1176-84. PubMed ID: 17077240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical practice. Screening for ovarian cancer.
    Clarke-Pearson DL
    N Engl J Med; 2009 Jul; 361(2):170-7. PubMed ID: 19587342
    [No Abstract]   [Full Text] [Related]  

  • 10. Progress report on ovarian cancer screening. Scientists are making headway in detecting ovarian cancer at an earlier stage.
    Harv Womens Health Watch; 2010 Apr; 17(8):1-3. PubMed ID: 20506601
    [No Abstract]   [Full Text] [Related]  

  • 11. Imaging and Screening of Ovarian Cancer.
    Lowry KP; Lee SI
    Radiol Clin North Am; 2017 Nov; 55(6):1251-1259. PubMed ID: 28991564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer.
    van Nagell JR; DePriest PD; Reedy MB; Gallion HH; Ueland FR; Pavlik EJ; Kryscio RJ
    Gynecol Oncol; 2000 Jun; 77(3):350-6. PubMed ID: 10831341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical performance of a multivariate index assay for detecting early-stage ovarian cancer.
    Longoria TC; Ueland FR; Zhang Z; Chan DW; Smith A; Fung ET; Munroe DG; Bristow RE
    Am J Obstet Gynecol; 2014 Jan; 210(1):78.e1-9. PubMed ID: 24055582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of symptomatic women for early diagnosis of ovarian cancer: results from the prospective DOvE pilot project.
    Gilbert L; Basso O; Sampalis J; Karp I; Martins C; Feng J; Piedimonte S; Quintal L; Ramanakumar AV; Takefman J; Grigorie MS; Artho G; Krishnamurthy S;
    Lancet Oncol; 2012 Mar; 13(3):285-91. PubMed ID: 22257524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian cancer screening.
    van Nagell JR; Pavlik EJ
    Clin Obstet Gynecol; 2012 Mar; 55(1):43-51. PubMed ID: 22343228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results from an ultrasound-based familial ovarian cancer screening clinic: a 10-year observational study.
    Tailor A; Bourne TH; Campbell S; Okokon E; Dew T; Collins WP
    Ultrasound Obstet Gynecol; 2003 Apr; 21(4):378-85. PubMed ID: 12704748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Women's awareness of ovarian cancer risks and symptoms.
    Lockwood-Rayermann S; Donovan HS; Rambo D; Kuo CW
    Am J Nurs; 2009 Sep; 109(9):36-45; quiz 46. PubMed ID: 19704232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian status in healthy postmenopausal women.
    Healy DL; Bell R; Robertson DM; Jobling T; Oehler MK; Edwards A; Shekleton P; Oldham J; Piessens S; Teoh M; Mamers P; Taylor N; Walker F
    Menopause; 2008; 15(6):1109-14. PubMed ID: 18536617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population screening and early detection of ovarian cancer in asymptomatic women.
    Nelson AE; Francis JE; Zorbas H;
    Aust N Z J Obstet Gynaecol; 2009 Oct; 49(5):448-50. PubMed ID: 19780723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the early detection of ovarian carcinoma.
    Garner EI
    J Reprod Med; 2005 Jun; 50(6):447-53. PubMed ID: 16050569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.